The Candriam Sustainable Global Equity Fund has been awarded a “5 IP” rating from Research IP, with a score of 4.29/5.
The Candriam Sustainable Global Equity Fund is a core-strategy global developed markets equity fund benchmarked to the MSCI World, in AUD and with net dividends reinvested.
What is the Fund’s competitive advantage?
Qualitative Research Report and Data Tear Sheet
Research IP says
“Research IP highlights the influence of two separate teams in managing this Fund, the Quantitative Equity Management Team (lead by Bart Goosens) and the ESG Investment and Research Team (lead by Wim Van Hyfte). Goosens has over 27 years’ experience including 24 at this firm. The team overall have on average over 20 years’ experience. The academic qualifications of the team are predominantly in finance, economics, and accounting. The team lead by Van Hyfte is in charge of providing information on ESG to all investment teams irrespective of strategy. This dedicated ESG team is large in absolute terms but also proportionate to rest of investment team. There are 19 ESG analysts, where 18 are focused on corporate investments, with 1 on government holdings. Within this is also a dedicated engagement team.“
“Research IP believes this is one of the few 360-degree ESG processes. To date this has been well executed. The challenge will be staying on top of the multi-faceted approach in a changing landscape.“
“Research IP notes that this strategy is categorised as ‘Article 9’ according to the European Union’s Sustainable Finance Disclosure Regulation. This means the Manager has met the regulatory technical standards for the investment product that demonstrates the integration of sustainability risks and a sustainable investment objective. Most funds Research IP has reviewed readily claim Article 8. Article 9 is viewed very much as the next level up and requires greater focus and attention to detail.”
Research IP, 1 December 2022
If you have any questions in relation to this report or the Research IP services, please contact us here.
Disclaimer, Disclosures and Warnings
Research IP strongly recommends this document and report be read in conjunction with the relevant Product Disclosure Statement. Research IP gives no warranty of accuracy or completeness of information in this document. Any information, opinions, views or recommendations are general information only and do not take into consideration any person’s particular financial situation or goals and therefore does not constitute financial advice. This document should not be relied upon as a substitute for financial advice from your financial adviser.